Teladoc Health, Inc.
—- Market cap
- —
- Debt
- +$1.04B
- Cash
- −$781.08M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TDOC stock price vs ADNT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ADNT's multiple
Needs ADNT P/S.
Implied fair value · at TDOC's multiple
Needs TDOC P/S.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TDOC FY 2025 (ended Dec 31, 2025) · ADNT FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Adient plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.75x
1.35x
Net debt / EBITDA
Leverage against operating earnings
0.87x
—
Cash and equivalents
Liquid reserves on the balance sheet
$781.08M
—
Total debt
Interest-bearing obligations outstanding
$1.04B
$2.39B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Hims & Hers Health, Inc.
TDOC vs HIMS
GoodRx Holdings, Inc.
TDOC vs GDRX
Cigna Group
TDOC vs CI
VEEVA SYSTEMS INC
TDOC vs VEEV
AMERICAN AXLE & MANUFACTURING HOLDINGS INC
TDOC vs AXL
VISTEON CORP
TDOC vs VC
DANA INC
TDOC vs DAN
BORGWARNER INC
TDOC vs BWA
FOX FACTORY HOLDING CORP
TDOC vs FOXF
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.